Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study Investigating the Efficacy and Safety of HSK44459 Tablet Administered to Participants With Atopic Dermatitis

NCT06996912 is registered in ClinicalTrials.gov with Xizang Haisco Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT06996912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06996912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study Investigating the Efficacy and Safety of HSK44459 Tablet Administered to Participants With Atopic Dermatitis
Lead sponsor
Xizang Haisco Pharmaceutical Co., Ltd
Phase
Phase 2
Overall status
Active, not recruiting
Start date
May 22, 2025
Completion date
March 23, 2026
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis (ad)